Nils Bottler

Better breast cancer screening should be a universal offering to every woman in the world. Vara’s AI-powered software platform, created with screening radiologists in Germany, mitigates much of the human subjectivity associated with reading mammography results—and reduces the repetitive work screening physicians are routinely subjected to—we’re making breast cancer screening more effective, more measurable, and more accessible for everyone, everywhere. By democratising access to early screening around the world, we deliver measurable impact backed by clinical evidence. We are partnering globally, to deliver breast cancer screening where it is needed most.

Newsenselab GmbH has developed M-sense Migraine. The application supports migraine sufferers in reducing their headaches and dealing with their condition in a self-determined manner. The innovative digital treatment program was developed together with leading headache specialists.

We make medical information clear. We enable patient education and engagement with personalized patient videos, accessible on any device. Founded by a team of medical doctors and Internet industry veterans, Telesofia Medical's proprietary platform allows healthcare providers to automatically generate branded personalized educational videos for patients. The videos are tailored to the specific patient, directed to low literacy level, and available on devices with no need to install a specific application or codec. Telesofia's platform currently supports a wide variety of applications such as explaining proper use of medication, directing preparations for medical procedures, and providing discharge instructions. Videos can be personalized to each patient based on their demographics, lab results, specific medical instructions, specific product used, and more. The videos are easily integrated into existing workflows and platforms. The fully branded videos are sent to patients through text or email messages, or embedded in patient portals/apps.

CLEW Medical - The Future of Clinical Intelligence CLEW harnesses data and knowledge to improve ICU clinical outcomes while reducing hospital costs. We focus on big data and real time analytics in healthcare and provide a set of services for care givers; nurses, physicians and administrators.

Inovytec Medical Solutions Ltd. (“Inovytec”) specializes in cutting-edge technologies for medical emergencies’ first-line solutions, particularly for respiratory and cardiac critical aid. Inovytec products are designed to save lives where the first few minutes are crucial and dramatically affect patient’s outcome. Inovytec’s vision is to provide efficient live-saving devices for use by any first-responders, Anytime. Anywhere.

Angelini Ventures is the venture capital arm of Angelini Industries funded with a €300 million capital commitment to build and invest in early-stage companies that develop innovative ideas and solutions in biotechnology, digital health and life sciences. Angelini Ventures invests across Europe, North America, and Israel with a focus on brain health and consumer segments such as women, children and the elderly. The company is headquartered in Rome with a global team spread across Europe, Asia and the US to provide global perspective and capabilities.

Better breast cancer screening should be a universal offering to every woman in the world. Vara’s AI-powered software platform, created with screening radiologists in Germany, mitigates much of the human subjectivity associated with reading mammography results—and reduces the repetitive work screening physicians are routinely subjected to—we’re making breast cancer screening more effective, more measurable, and more accessible for everyone, everywhere. By democratising access to early screening around the world, we deliver measurable impact backed by clinical evidence. We are partnering globally, to deliver breast cancer screening where it is needed most.

Newsenselab GmbH has developed M-sense Migraine. The application supports migraine sufferers in reducing their headaches and dealing with their condition in a self-determined manner. The innovative digital treatment program was developed together with leading headache specialists.